Navigation Links
Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
Date:5/17/2011

ATLANTA, May 17, 2011 /PRNewswire/ -- Inhibikase Therapeutics, Inc. today announced the election Dr. Steven C. Gilman to the Board of Directors of Inhibikase Therapeutics, Inc.

(Logo: http://photos.prnewswire.com/prnh/20110517/CL02791LOGO)

Dr. Steven Gilman joined Cubist Pharmaceuticals in 2008 and currently serves as the Cubist's Executive Vice President, Research & Development and Chief Scientific Officer. Before joining Cubist Pharmaceuticals, Dr. Gilman held several positions with ActivBiotics, Inc., including Chairman of the board of directors and President and CEO. Previously Dr. Gilman worked at Millennium Pharmaceuticals, Inc., where he held a number of senior leadership roles including Vice President and General Manager, Inflammation. Additionally, Dr. Gilman served as Group Director at Pfizer Global Research and Development, where he was responsible for drug discovery of novel antibacterial agents as well as several other therapeutic areas.

Dr. Gilman currently serves on the Boards of Directors of the Massachusetts Biotechnology Association and the Massachusetts Society for Medical Research. In addition, Dr. Gilman serves on the Science and Regulatory Executive Committee of PhRMA. Dr. Gilman received his Ph.D. and M.S. degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinic and Research Foundation, and received a B.A. in microbiology from Miami University of Ohio.

Dr. Gilman joins Board members Dr. Stephen Fesik, Orrin H. Ingram, II Chair in Cancer Research at Vanderbilt University and former Vice-President for Cancer Research, Abbott Laboratories, Mr. David Gryska, former CFO of Celgene and Ms. Lisa Evren, Vice-President and Treasurer, Talisman-Energy.

"We are fortunate to add Dr. Gilman to the slate of new Board members elected in the last eight months.  Dr. Gilman's breadth of experience in pharmaceutical development and senior leadership will acceler
'/>"/>

SOURCE Inhibikase Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
2. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
3. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
4. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
5. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
6. Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
7. Echo Therapeutics Expands Into New Headquarters in Philadelphia
8. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
9. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
10. Amicus Therapeutics Announces First Quarter 2011 Financial Results and Continued Progress of Development Programs
11. Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Mich. , June 29, 2015  New ... and American Stroke Association give hope for better ... who experience an acute ischemic stroke each year. ... the key products used in the clinical trials ... The new AHA/ASA guidelines strongly recommend endovascular therapy ...
(Date:6/29/2015)...  Nevro Corp. (NYSE: NVRO ), a global ... for the treatment of chronic pain, today announced that ... of Intersect ENT (NASDAQ: XENT ), has been ... 2015. For the last seven years, ... a company dedicated to improving the quality of life ...
(Date:6/29/2015)... ZIONA, Israel , June 29, 2015 ... TASE: BVXV) today announced positive preliminary results from its ... for a universal influenza vaccine. In this trial, M-001 ... 50 to 65, followed by an administration of the ... M-001 was found to be safe and well tolerated ...
Breaking Medicine Technology:New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3
... YORK , June 24 Reportlinker.com announces that a new market research report ... Global Hernia Repair Devices ... http://www.reportlinker.com/p0209282/Global-Hernia-Repair-Devices-Industry.html , ... This report analyzes the Global market for Hernia Repair Devices in US$ Million by the ...
... June 24 Today the United ... (CDC) issued new and important guidelines on the detection ... of tuberculosis (TB). In these landmark guidelines, CDC advises ... now preferred over the 100+-year-old tuberculin skin test (TST) ...
Cached Medicine Technology:Reportlinker Adds Global Hernia Repair Devices Industry 2Reportlinker Adds Global Hernia Repair Devices Industry 3Reportlinker Adds Global Hernia Repair Devices Industry 4Reportlinker Adds Global Hernia Repair Devices Industry 5Reportlinker Adds Global Hernia Repair Devices Industry 6Reportlinker Adds Global Hernia Repair Devices Industry 7Reportlinker Adds Global Hernia Repair Devices Industry 8Reportlinker Adds Global Hernia Repair Devices Industry 9Reportlinker Adds Global Hernia Repair Devices Industry 10New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 2New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 3New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 4New CDC Guidelines Prefer Use of Blood Tests, Including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations 5
(Date:6/29/2015)... , ... June 29, 2015 , ... With Urgent Care ... a partnership with the American Board of Urgent Care Medicine and the Medical Society ... 1 Credit™ to Urgent Care physicians and health care professionals. , According to Matthew ...
(Date:6/29/2015)... , ... June 29, 2015 , ... OR Manager announced ... revitalized look and feel, as well as a redesigned logo and weekly eLetter. The ... but is now more user-friendly and easier to navigate. , In addition to ...
(Date:6/29/2015)... ... 29, 2015 , ... The Food Safety and Technology Research ... Kong Polytechnic University (PolyU) has developed a new method for rapid authentication of ... a long-term issue in food safety, and becomes particularly important with the emergence ...
(Date:6/29/2015)... ... June 29, 2015 , ... DISC, a ... is a popular focus for corporate training seminars. As many as seventy percent ... training, foster teamwork, and increase productivity. , With the demand for in-house ...
(Date:6/29/2015)... ... June 29, 2015 , ... Wheel:Life, ... Travel Guide for Wheelchair Users as a new e-book on Amazon.com. Wheel:Life publications ... , These accessible travel suggestions were crowdsourced by the Get Out & Enjoy ...
Breaking Medicine News(10 mins):Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 2Health News:Exam Master Partners to Provide New Urgent Care Continuing Medical Education Resource 3Health News:OR Manager Launches New Website 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3
... malady that many suffer from, it often breeds discomfort and ... to overcome it those struggling with this malady ... in causing bad breath//. In the absence of any clear-cut ... mouth rinses are usually resorted to. ,Statistics ...
... in the gray matter has offered an insight into a ... introduction – SELFISHNESS//. Bewildering all the same, why are some ... others believe in being the epitome of selflessness! ... at the front of the brain, termed as the dorsolateral ...
... caught between the devil and the deep sea, unable to ... of emergency mental// healthcare. The patient, a 17 year old ... form of counseling was attempted. ,The girl suffered ... suicide attempts. According to the mother, her daughter was ...
... According to the Idaho health officials, the kid who died ... E. coli strain in the tainted spinach that has caused ... boy, Kyle Allgood, from Chubbuck, Idaho, who died on Sept. ... bacteria outbreak that has sickened 192 people in the United ...
... first time issued Global Air Quality Guidelines on Thursday so ... million// people each year with most of the deaths occurring ... to enhance air quality in the cities. A statement issued ... 3,00,000 lives could be saved every year by bringing down ...
... Andhra Pradesh carry the HIV virus, which is passed on to ... (APSACS) has come to the aid of such infants, suffering HIV ... society strives to realize infant births sans HIV by the year ... country, the group has lined up the Telugu Network of HIV ...
Cached Medicine News:
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: